Complete Genomics, Inc. Appoints Chief Commercial Officer and Chief Medical Officer

MOUNTAIN VIEW, Calif., Aug. 25, 2011 (GLOBE NEWSWIRE) -- Complete Genomics Inc. (Nasdaq:GNOM), the complete human genome sequencing company, today announced it has appointed Keith Raffel as chief commercial officer (CCO) and Dr. Jill Hagenkord as chief medical officer (CMO). Both executives will support continued growth in the company’s service offerings and spearhead the development of new products to deliver high-quality, cost-effective genomic data and analysis.

MORE ON THIS TOPIC